The Hematologist

banner image

How We Mark Time and How Time Marks Us

Dr. Gotlib discusses the road to approval of midostaurin for the treatment of advanced systemic mastocytosis.

Read more
banner image

Ask the Hematologist

Dr. Moss evaluates a case that requires CAR-T cell therapy and discusses practical issues hematologists should be aware of during introduction of the treatment.

Read more
banner image

Podcast: Farming Hematopoietic Stem Cells

Dr. Hoggatt and Dr. George Daley discuss efforts to grow hematopoietic stem cells to care for patients with diseases treatable with bone marrow transplantation.

Play here
Current Issue Static Feature

Current Issue

September/October 2017              
Volume 14, Issue 5

Read current issue

President's Column

Presidents Column - Kenneth AndersonKraft Family Professor of Medicine, Harvard Medical School; Director Lebow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center Dana-Farber Cancer Institute, Boston, MA
Staying Vigilant on Health Care Reform
September 1, 2017

Dr. Kenneth Anderson discusses ASH's role in health care reform.

View all president's column articles

  • NCATS Seeking Information on Opportunities and Challenges for Platform Vector Human Gene Therapy Trials in Rare Diseases
    September 01, 2017

    The National Center for Advancing Translational Sciences (NCATS) released a request for information soliciting input on the use of viral vectors as platforms for therapeutic gene delivery to specific organs or cell types, and how such platforms might be developed most efficiently in clinical trials for the treatment of multiple diseases.

  • Congress Changes Stance on ACA Repeal and Replace
    July 24, 2017

    On July 13, 2017, the U.S. Senate released an updated version of the Better Care Reconciliation Act (BCRA), legislation to repeal large provisions of the Affordable Care Act (ACA).

  • DEA Eliminates Grace Period for Registration Renewal
    December 21, 2016

    Through a notice on its website, the Drug Enforcement Administration (DEA) recently announced significant changes to its registration renewal process. Effective January 1, 2017, the DEA is eliminating the informal grace period which the agency has previously allowed for registrants to renew their registrations. 

  • CMS Announces End to Medicare Part B Drug Payment Model
    December 20, 2016

    On December 15, 2016, the Centers for Medicare and Medicaid Services (CMS) announced the cancellation of Medicare Part B Drug Payment Model.  CMS initially proposed the demonstration on March 8, 2016 to test new models in how physician-administered drugs are paid under the Medicare program.

View all Policy News